Latest Updates
-
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens -
The Sunscreen Confusion: Expert Explains How to Choose What Actually Works in Indian Weather -
On Goa Liberation Day 2025, A Look At How Freedom Shaped Goa Into A Celebrity-Favourite Retreat -
Daily Horoscope, Dec 19, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs -
Paush Amavasya 2025: Do These Most Powerful Rituals For Closure On The Final Amavasya Of The Year
WHO Warns: World Running Out Of Antibiotics, What Next?
What happens when there are no antibiotics? Check here for details.
Antibiotics that are currently in clinical development are insufficient to combat the growing threat of antimicrobial resistance, a World Health Organisation (WHO) report said.
Most of the drugs currently in the clinical phase are modifications of existing classes of antibiotics and are only short-term solutions, WHO said.
There are, however, very few potential treatment options. The growing resistant infections pose the greatest threat to health, including drug-resistant tuberculosis (TB) which kills around 250,000 people each year.
There are also very few oral antibiotics in the pipeline, yet these are essential formulations for treating infections outside hospitals or in resource-limited settings, the report said.

"Antimicrobial resistance is a global health emergency that will seriously jeopardise progress in modern medicine," Tedros Adhanom Ghebreyesus, Director-General of WHO, said in a statement on Wednesday.
"There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB, otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery," Ghebreyesus added.
Besides TB, the WHO has also identified 12 classes of priority pathogens including common infections like pneumonia or urinary tract infections that are increasingly resistant to existing antibiotics and urgently in need of new treatments.

Among the newly identified 51 new antibiotics and biologicals in clinical development, only eight are classed by WHO as innovative treatments that will add value to the current antibiotic treatment arsenal, it said.
"Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days because we have no line of defence," noted Suzanne Hill, Director of the Department of Essential Medicines at WHO.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











